UPDATE
1-Merck scraps development of
osteoporosis drug due to
stroke risk
Sept 2 (Reuters) - Merck & Co Inc said it would stopdeveloping its experimental
osteoporosis drug after anindependent analysis confirmed the treatment raises the
risk ofstroke.
